Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Founder mutations among the Dutch.

Maurice P A Zeegers1, Frans van Poppel, Robert Vlietinck

  • 1Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.

European Journal of Human Genetics : EJHG
|March 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Rare Is Common-Rethinking Pediatric Genetic Care.

JAMA·2026
Same author

Association of Intratumoral Microbiota with Prognosis in Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with <i>NF1</i> point variants.

Journal of medical genetics·2025
Same author

The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium.

Nutrition and cancer·2025
Same author

Virusplot: a web server for viral integration analysis and visualization.

Frontiers in oncology·2025
Same author

A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same journal

Australian parents' perspectives on extended genomic screening: what information to return and when?

European journal of human genetics : EJHG·2026
Same journal

Perspectives on phenotype in genetic testing for early-onset atrial fibrillation.

European journal of human genetics : EJHG·2026
Same journal

Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-rare recessive disorders.

European journal of human genetics : EJHG·2026
Same journal

Decoding splicing variants in high-throughput sequencing: a functional validation approach integrating deep learning tools.

European journal of human genetics : EJHG·2026
Same journal

How parents decide whether to have genomic newborn screening: experiences from BabyScreen.

European journal of human genetics : EJHG·2026
Same journal

Psychosocial outcomes of reproductive genetic carrier screening up to five years post-result.

European journal of human genetics : EJHG·2026
See all related articles

Founder mutations in the Dutch population offer insights into genetic homogeneity and disease prevalence. Studying these genetic markers aids in understanding population history and facilitates gene discovery for various disorders.

Area of Science:

  • Population Genetics
  • Human Genetics
  • Medical Genetics

Background:

  • Founder mutations are key to understanding genetic disorder prevalence and population homogeneity.
  • The Dutch population's history, marked by migration and endogamy, shaped its genetic landscape.
  • Historical events like invasions and migrations influenced the genetic makeup of the Netherlands.

Observation:

  • Founder mutations are identified within Dutch genetic isolates and the broader population.
  • Specific mutations are linked to conditions such as benign familial cholestasis, diabetes mellitus type I, and hereditary breast-ovarian cancer.
  • Many founder mutations exhibit regional distributions, indicating dissemination from a common ancestor.

Findings:

  • The Dutch population exhibits limited genetic heterogeneity for numerous genetic conditions due to shared identical-by-descent chromosomal regions.

Related Experiment Videos

  • Founder mutations in the Dutch are found in specific isolates and across the general population, including those for hereditary cancers and metabolic disorders.
  • Shared mutations with other European populations and transmission to descendants in North America and South Africa highlight migration patterns.

    • Implications:

    • Founder mutations in the Dutch provide valuable models for studying disease prevalence and penetrance.
    • The genetic homogeneity observed presents opportunities for discovering genes responsible for other diseases and traits.
    • Understanding founder effects in the Dutch population can inform genetic counseling and disease management strategies.